RPL21P71

Across TCGA pan-cancer cohorts, RPL21P71 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPL21P71 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPL21P71 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL21P71 expression acts as an unfavorable survival marker, although some lineages such as COAD and DLBC show a favorable association.

ACC, KICH, and COAD are the cancer types where RPL21P71 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	II,III,IV	0.541	0.938	<.001	90	view →
KICH	DFS	Tertile	All	0.504	0.907	<.001	78	view →
COAD	DFS	Quartile	All	0.687	0.482	.001	56	view →
KIRC	DFS	Tertile	II,III,IV	0.377	0.593	.001	54	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
TGCT	OS	Tertile	All	0.917	1.000	.001	36	view →
DLBC	DFS	Tertile	All	1.000	0.363	.004	27	view →
PCPG	DFS	Tertile	All	0.825	0.971	.006	21	view →
UVM	OS	Tertile	All	0.727	0.941	.033	15	view →
LUAD	DFS	Tertile	III,IV	0.412	0.705	.002	15	view →
THYM	OS	Median	II,III,IV	1.000	0.651	.012	10	view →
OV	OS	Quartile	III,IV	0.628	0.706	.032	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPL21P71–ACC (OS)

Open the ACC breakdown →